US Patent 8765924 Modified erythropoietin
Patent 8765924 was granted and assigned to Prolong Pharmaceuticals on July, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8765924 Modified erythropoietin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.